NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.
Carolina Rodriguez-TiradoNupura KaleMaria J CarliniNitisha ShrivastavaAlcina A RodriguesBassem D KhalilJose Javier Bravo-CorderoYan HongMelissa AlexanderJiayi JiFariba BehbodMaria Soledad SosaPublished in: Cancer research (2022)
During early stages of breast cancer progression, HER2-mediated suppression of NR2F1 promotes dissemination by inducing EMT and a hybrid luminal/basal-like program.